David S. Simmons

David S. Simmons (chief executive) discloses dealings in 3 companies, chiefly PPD, Inc., Viatris Inc and Accendra Health Inc/VA/. In total, 24 filings cover trades dated from 6 May 2016 to 6 March 2026.

In open-market terms, that means 3 purchases worth €991k on one side and 3 sales worth €6.7M on the other. Taken together, the sales exceed the purchases by €5.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants and 4 option exercises. 2026 to date brings 2 purchases and no sales.

In size, the median ticket on the buying side is €2,559. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 10 March 2026, reports an option exercise in Viatris Inc. The latest purchase dates back some time: it was published 227 days ago, on 10 March 2026. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.